Doctors Genetics Hormones Protein 
Drug Discovery World
AUGUST 16, 2023
A new study has shed light on the genetic messages encoded by genes within ‘triple negative’ breast cancers (TNBC), and shows they could predict response to chemotherapy. The presence of these biomarkers could be used to accelerate the development of more personalised treatments for triple negative breast cancers.
The Pharma Data
JANUARY 21, 2021
Doctors need better tools to evaluate the status of COVID-19 patients as early as possible because many of the treatments—such as monoclonal antibodies—are in short supply, and we know that some patients will get better without intensive treatments,” said co-senior author Andrew E. The research was published in the journal JCI Insight.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
MAY 15, 2021
Now imagine the entire length of the field as the 300,000 years of human genetic evolution. However your genetic code IS hardwired to go without food for short periods between times of plenty. What if there was a near “magical” fat burning hormone?… Especially meals that are high in sugar and protein.
The Pharma Data
MAY 14, 2021
We have many hormones in our bodies, but when they are balanced they keep our bodies and our hair healthy. One of the most important hormones is Testosterone. While it is considered a men’s hormone, both men and women need it to grow and heal bones and muscles. But this hair growth is permanent and the results are real.
The Pharma Data
JUNE 18, 2021
The BTK protein sends important signals that tell B cells to mature and produce antibodies. Call your doctor for medical advice about side effects. About VENCLEXTA ® /VENCLYXTO ® (venetoclax) VENCLEXTA ® /VENCLYXTO ® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein.
The Pharma Data
JUNE 18, 2021
The BTK protein sends important signals that tell B cells to mature and produce antibodies. VENCLEXTA ® /VENCLYXTO ® (venetoclax) is a first-in-class medicine that selectively binds and inhibits the B-cell lymphoma-2 (BCL-2) protein. VENCLXEXTA/VENCLYXTO targets the BCL-2 protein and works to help restore the process of apoptosis.
The Pharma Data
MAY 14, 2021
All the scientific studies… And the words straight from a doctor’s mouth… So you’ll have everything you need… By the way, my name is Matt Stirling. It’s all based on human biology… I refer to it as your “metabolism switch”… But the scientific name for it is AMP-activated protein kinase….
Expert insights. Personalized for you.
52 
Let's personalize your content